A Boston Scientific executive said the guidance will expand access to a targeted, minimally invasive treatment for tumors that have metastasized to the liver.
A Boston Scientific executive said the guidance will expand access to a targeted, minimally invasive treatment for tumors that have metastasized to the liver.